AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 146 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $122 | +18.4% | 20,112 | +18.8% | 0.00% | 0.0% |
Q4 2023 | $103 | -53.4% | 16,935 | -67.7% | 0.00% | -66.7% |
Q3 2023 | $221 | +268.3% | 52,455 | +21.2% | 0.00% | +200.0% |
Q1 2023 | $60 | -100.0% | 43,282 | -30.5% | 0.00% | -50.0% |
Q3 2022 | $126,000 | +70.3% | 62,243 | +300.4% | 0.00% | – |
Q4 2021 | $74,000 | -64.6% | 15,547 | -60.3% | 0.00% | -100.0% |
Q3 2021 | $209,000 | +80.2% | 39,120 | +127.8% | 0.00% | 0.0% |
Q1 2021 | $116,000 | +34.9% | 17,170 | -9.0% | 0.00% | – |
Q4 2020 | $86,000 | -68.8% | 18,876 | -67.4% | 0.00% | -100.0% |
Q2 2020 | $276,000 | +93.0% | 57,907 | +40.6% | 0.00% | +100.0% |
Q1 2020 | $143,000 | +95.9% | 41,196 | +170.6% | 0.00% | 0.0% |
Q4 2019 | $73,000 | +135.5% | 15,224 | +40.4% | 0.00% | – |
Q3 2019 | $31,000 | -98.4% | 10,844 | -95.9% | 0.00% | -100.0% |
Q2 2019 | $1,906,000 | +892.7% | 265,834 | +1776.4% | 0.01% | +550.0% |
Q4 2018 | $192,000 | +60.0% | 14,167 | +93.0% | 0.00% | +100.0% |
Q2 2018 | $120,000 | – | 7,342 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 4,655,403 | $29,561,809 | 9.98% |
TPG GP A, LLC | 12,328,767 | $78,287,670 | 1.80% |
Rubric Capital Management LP | 10,721,778 | $68,083,290 | 1.78% |
TUCKER ASSET MANAGEMENT LLC | 1,111,064 | $7,055,256 | 1.54% |
BlackBarn Capital Partners LP | 2,000,000 | $12,700,000 | 1.13% |
Nantahala Capital Management | 2,669,943 | $16,954,138 | 1.00% |
SANDERS MORRIS HARRIS LLC | 567,196 | $3,601,695 | 0.59% |
Jackson Creek Investment Advisors LLC | 161,760 | $1,027 | 0.38% |
HENNESSY ADVISORS INC | 1,388,600 | $8,817,610 | 0.33% |
Signature Wealth Management Partners, LLC | 66,666 | $423,329 | 0.32% |